2017 Press Releases Keyword Search Year: 20202019201820172016201520142013 May 19, 2016 Summary ToggleAgios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association May 17, 2016 Summary ToggleAgios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement May 17, 2016 Summary ToggleAgios Updates 2016 Financial Guidance May 5, 2016 Summary ToggleAgios Reports First Quarter 2016 Financial Results May 2, 2016 Summary ToggleAgios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016 Mar 30, 2016 Summary ToggleAgios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZA® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy Mar 1, 2016 Summary ToggleAgios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8 Feb 18, 2016 Summary ToggleAgios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones Feb 11, 2016 Summary ToggleAgios to Webcast Conference Call of Fourth Quarter and Full Year 2015 Financial Results on February 18, 2016 Feb 8, 2016 Summary ToggleAgios Appoints Steve Hoerter as Chief Commercial Officer Feb 3, 2016 Summary ToggleAgios to Present at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10 Jan 11, 2016 Summary ToggleAgios Outlines Key 2016 Goals and Priorities Jan 4, 2016 Summary ToggleAgios to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11 Dec 18, 2015 Summary ToggleAgios Announces Initiation of Phase 1b Frontline Trial of AG-221 or AG-120 in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Dec 6, 2015 Summary ToggleAgios Announces Data from Ongoing Phase 1/2 Trial of AG-221 Showing Durable Responses in Patients with Advanced Hematologic Malignancies Dec 5, 2015 Summary ToggleAgios Announces Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Responses in Patients with Advanced Hematologic Malignancies Nov 8, 2015 Summary ToggleAgios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors Nov 5, 2015 Summary ToggleAgios to Present New Data From Lead Programs at the 2015 ASH Annual Meeting Nov 5, 2015 Summary ToggleAgios Reports Third Quarter 2015 Financial Results Nov 3, 2015 Summary ToggleAgios to Present at Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10 Oct 29, 2015 Summary ToggleAgios to Webcast Conference Call of Third Quarter 2015 Financial Results on November 5, 2015 Oct 26, 2015 Summary ToggleAgios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial in Advanced Solid Tumors at AACR-NCI-EORTC Oct 16, 2015 Summary ToggleAgios Outlines Key Clinical Development & Research Strategies Oct 8, 2015 Summary ToggleAgios to Webcast R&D Day on October 16, 2015 Sep 23, 2015 Summary ToggleAgios to Present at Leerink Partners Rare Disease Roundtable Aug 6, 2015 Summary ToggleAgios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress Aug 5, 2015 Summary ToggleAgios to Present at Canaccord Genuity 35th Annual Growth Conference Wednesday, August 12, 2015 Jul 30, 2015 Summary ToggleAgios to Webcast Conference Call of Second Quarter 2015 Financial Results on August 6, 2015 Jun 24, 2015 Summary ToggleAgios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation Jun 23, 2015 Summary ToggleAgios Appoints Maykin Ho, Ph.D., to its Board of Directors Jun 12, 2015 Summary ToggleAgios Reports New, Final Data from Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers for AG-348, an Investigational Medicine for Pyruvate Kinase (PK) Deficiency Jun 12, 2015 Summary ToggleAgios Announces New Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies Jun 12, 2015 Summary ToggleAgios Announces New Data from Ongoing Phase 1 Dose Escalation and Expansion Trial of AG-221 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies Jun 10, 2015 Summary ToggleAgios Pharmaceuticals Announces FDA Orphan Drug Designation Granted to AG-120 for Treatment of IDH1-Mutant Positive Acute Myelogenous Leukemia May 21, 2015 Summary ToggleAgios to Present Clinical and Preclinical Data at the 20th Congress of the European Hematology Association May 18, 2015 Summary ToggleAgios Announces FDA Fast Track Designation Granted to AG-120 for Treatment of Patients with Acute Myelogenous Leukemia with an IDH1 Mutation May 7, 2015 Summary ToggleAgios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120 Apr 29, 2015 Summary ToggleAgios Pharmaceuticals Selects Third Novel IDH Mutant Inhibitor, AG-881, for Clinical Development Apr 28, 2015 Summary ToggleAgios Pharmaceuticals to Webcast Conference Call of First Quarter 2015 Financial Results on May 7, 2015 Mar 24, 2015 Summary ToggleAgios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency Feb 20, 2015 Summary ToggleAgios Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference on Monday, March 2 Feb 17, 2015 Summary ToggleAgios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results Feb 10, 2015 Summary ToggleAgios Pharmaceuticals to Webcast Conference Call of Fourth Quarter and Full Year 2014 Financial Results on February 17, 2015 Feb 3, 2015 Summary ToggleAgios Pharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11 Jan 12, 2015 Summary ToggleAgios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last